doi: 10.1016/s0960-894x(99)00288-7.
The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor
Affiliations
- PMID: 10406640
- DOI: 10.1016/s0960-894x(99)00288-7
Item in Clipboard
The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor
Bioorg Med Chem Lett.
.
Abstract
The development of a COX-2 inhibitor rofecoxib (MK 966, Vioxx) is described. It is essentially equipotent to indomethacin both in vitro and in vivo but without the ulcerogenic side effect due to COX-1 inhibition.
Similar articles
-
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.J Pharmacol Exp Ther. 1999 Aug;290(2):551-60. J Pharmacol Exp Ther. 1999. PMID: 10411562
-
Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx).Bioorg Med Chem Lett. 2000 Dec 4;10(23):2683-6. doi: 10.1016/s0960-894x(00)00538-2. Bioorg Med Chem Lett. 2000. PMID: 11128651
-
Sulfonamido, azidosulfonyl and N-acetylsulfonamido analogues of rofecoxib: 4-[4-(N-acetylsulfonamido)phenyl]-3-(4-methanesulfonylphenyl)-2(5H)furanone is a potent and selective cyclooxygenase-2 inhibitor.Bioorg Med Chem Lett. 2004 Apr 19;14(8):1957-60. doi: 10.1016/j.bmcl.2004.01.076. Bioorg Med Chem Lett. 2004. PMID: 15050636
-
[Selective cyclooxygenase 2 inhibitors (COX-2)].Postepy Hig Med Dosw. 2001;55(2):287-302. Postepy Hig Med Dosw. 2001. PMID: 11468975 Review. Polish.
-
[Withdrawal of rofecoxib (Vioxx): what about cardiovascular safety of COX-2 selective non-steroidal anti-inflammatory drugs?].Rev Med Liege. 2004 Oct;59(10):565-9. Rev Med Liege. 2004. PMID: 15623076 Review. French.
Cited by
-
Pharmacological exploitation of an off-target antibacterial effect of the cyclooxygenase-2 inhibitor celecoxib against Francisella tularensis.Antimicrob Agents Chemother. 2009 Jul;53(7):2998-3002. doi: 10.1128/AAC.00048-09. Epub 2009 Apr 27. Antimicrob Agents Chemother. 2009. PMID: 19398640 Free PMC article.
-
Role of water in cyclooxygenase catalysis and design of anti-inflammatory agents targeting two sites of the enzyme.Sci Rep. 2020 Jul 1;10(1):10764. doi: 10.1038/s41598-020-67655-6. Sci Rep. 2020. PMID: 32612190 Free PMC article.
-
Design, Synthesis and Biological Evaluation of New Imidazo[2,1-b]Thiazole Derivatives as Selective COX-2 Inhibitors.Iran J Pharm Res. 2018 Fall;17(4):1288-1296. Iran J Pharm Res. 2018. PMID: 30568687 Free PMC article.
-
Identification and characterization of carprofen as a multitarget fatty acid amide hydrolase/cyclooxygenase inhibitor.J Med Chem. 2012 Oct 25;55(20):8807-26. doi: 10.1021/jm3011146. Epub 2012 Oct 8. J Med Chem. 2012. PMID: 23043222 Free PMC article.
-
Are Cox-2 drugs the second line option in indomethacin responsive headaches?J Headache Pain. 2010 Oct;11(5):405-7. doi: 10.1007/s10194-010-0225-0. Epub 2010 Jun 2. J Headache Pain. 2010. PMID: 20517705 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Research Materials
